Close Menu

GOTHENBURG, Sweden (GenomeWeb) – Noninvasive prenatal genetic tests for detecting fetal disorders and preconception tests to assess disease recurrence risk continue to advance. At the European Human Genetics Conference here in Gothenburg yesterday, researchers presented two new noninvasive prenatal testing methods and a new way to determine recurrence risk for diseases caused by a de novo mutation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.